3629 results for «722»
3629 results
Trial updates and featured clinical research
16 May 2024 – From EuroPCR 2024
This session showcases a selection of the latest clinical research and trial updates presented at EuroPCR 2024. Attendees will have the opportunity to learn about the findings from studies evaluating the use of OCT-guided PCI for chronic total occlusions, the safety and efficacy of short dual...
Coronary issues before, during and after TAVI
16 May 2024 – From EuroPCR 2024
This session presents a series of challenging clinical cases highlighting the complex interplay between coronary artery disease and transcatheter aortic valve implantation (TAVI). Attendees will witness real-world scenarios, including high-risk PCI with concomitant severe aortic stenosis, the management of degenerated aortic bioprostheses with the risk of...
Other coronary interventions: SSO2, angioPy & more
16 May 2024 – From EuroPCR 2024
This session showcases a diverse array of innovative coronary interventions and technologies, including the use of super-saturated oxygen therapy in STEMI, the validation of intracoronary flow velocity measurement, the application of laser and optics-based coronary intravascular lithotripsy, and the development of contrast-free and X-ray-free PCI techniques....
The landscape of structural heart interventions
16 May 2024 – From EuroPCR 2024
This session provides a comprehensive overview of the management of structural heart disease, focusing on the differences in procedural approaches for aortic and mitral interventions. Attendees will learn effective strategies to manage procedural complications, as well as how to adapt patient pathways for various structural heart...
Percutaneous tricuspid treatment in challenging anatomies
16 May 2024 – From EuroPCR 2024
Watch this session on percutaneous tricuspid treatment to explore key cases, including managing tricuspid valve-in-valve implantation in a patient with a giant right atrium, transcatheter edge-to-edge repair post-Mustard procedure, and tricuspid replacement in a challenging extreme anatomy case. You'll also learn about cross-caval treatment for torrential...
Acute coronary syndrome caused by coronary aneurysms
16 May 2024 – From EuroPCR 2024
This session will explore various cases of acute coronary syndromes caused by coronary artery aneurysms. Participants will learn about the diagnosis, management, and treatment strategies for these rare and complex cases, including the use of imaging and interventional techniques to address the underlying pathology.
PCI complications: mistakes in stent placement, stent elongation during implantation & more
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focusing on various PCI complications, including mistakes in stent placement, stent elongation during implantation, and unexpected stent behavior after post-dilatation. The cases are presented with interactive discussions to enhance understanding of these complex scenarios and their management.
Thrombectomy for pulmonary embolism
16 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on catheter-directed therapy for pulmonary embolism. It includes presentations and discussions on an intelligent CT vacuum aspiration thrombectomy system, outcomes of catheter-directed therapy in intermediate-high and high-risk pulmonary embolism, and functional and quality of life outcomes in...
"Rock" around the clock: differential use of the dedicated tools to deal with coronary calcific lesions
16 May 2024 – From EuroPCR 2024
This session, with the collaboration of the Argentinian College of Interventional Cardioangiologists (CACI), Italian Society of Interventional Cardiology (SICI-GISE) and Interventional Department of the Chilean Society of Cardiology, provides insights on modern treatment algorithms for calcific coronary lesions. It covers best practices for different devices to...
Advancements in intracoronary imaging and intervention: unmasking vulnerable plaques and optimising durable PCI outcomes
16 May 2024 – From EuroPCR 2024
Delve into this EuroPCR 2024 session to gain insights into NIRS IVUS, exploring its applications, supported by current data, and understanding its clinical significance. Learn how to utilize NIRS IVUS in PCI planning through case examples, addressing lesion characteristics such as length and calcific nodules. Explore local...
Targeting inflammation in AMI: a debate
14 May 2024 – From EuroPCR 2024
Watch this session to explore inflammation's role in AMI, from atherosclerosis to post-infarct remodeling. Find out more about IL-6's significance in future MACE risk and cardiac status deterioration post-AMI, and delve into targeting inflammation via IL-6, evaluating short and long-term impacts.
Physiology guided post-DCB treatment to safely limit stenting. Validation in complex clinical settings with the optical Optowire III pressure guidewire
16 May 2024 – From EuroPCR 2024
Follow this session to discover how accurate resting index can inform decision-making for DCB in CTO patients and understand the role of physiology in a new PCI workflow for complex MVD. Thus, you will learn about a DCB intention-to-treat strategy guided by post-PCI coronary physiology in...
Revisiting thrombus aspiration in STEMI with continuous power aspiration system
15 May 2024 – From EuroPCR 2024
Tune into this 2024 session for insights into the latest ESC guidelines, strategies to prevent and treat no reflow, and an examination of trials like TASTE, TAPAS, and TOTAL on coronary thrombus management. Explore also the outcomes of the CHEETAH study, pondering a potential paradigm shift,...
Ultra-low contrast techniques to improve the safety and quality of PCI in complex and high-risk patients
14 May 2024 – From EuroPCR 2024
Tune in to this session to discover how reducing reliance on contrast opacification enhances procedural safety and enables more thorough revascularization in complex PCI scenarios. Learn that ultra-low contrast (ULC) PCI encompasses various interventional skills and specialized tools, many already familiar to interventional cardiologists. Embrace a...
Solving challenging PCI with laser atherectomy: the forgotten Swiss knife?
15 May 2024 – From EuroPCR 2024
Watch this session to enhance your understanding of laser atherectomy fundamentals, recognize its role in addressing complex lesions like in-stent restenosis and uncrossable lesions, and acquire tips and techniques for ensuring procedural efficiency and safety.
uRDN now - The third pillar for hypertension treatment
16 May 2024 – From EuroPCR 2024
Tune into this session to stay updated on the cutting-edge clinical evidence, guidelines, and technology surrounding renal denervation. Explore firsthand clinical experiences with ultrasound renal denervation and gain practical insights into patient selection through individual, real-world case discussions. Engage in discussions on integrating ultrasound renal denervation...
Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options
15 May 2024 – From EuroPCR 2024
In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...
From innovation to reality: the impact of Cre8 EVO technology on complex PCI
15 May 2024 – From EuroPCR 2024
This session is a good opportunity to delve into the contemporary technical and clinical complexities surrounding complex PCIs in challenging patient cases. Explore the necessary tools and treatment strategies to enhance peri-procedural and long-term clinical outcomes, and follow discussions on the unique technologies of Cre8 EVO...
Complex PCI in ACS patient with high bleeding risk: optimise the strategy
15 May 2024 – From EuroPCR 2024
Watch this session for insights into managing acute coronary syndrome patients with multivessel disease, updates on treatment approaches, comparing FULL RESVAC with previous trials like COMPLETE or FIRE, for example, and information on ongoing trials such as FRAMI-AMI 2 and 3. Explore the LIVE case presentation...
LANDMARK RCT - Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
15 May 2024 – From EuroPCR 2024
This session provides an overview of the early outcomes of the LANDMARK trial, a randomized non-inferiority trial comparing TAVI devices. It examines baseline characteristics, the significance of intermediate sizes according to MSCT recommendations, real-world representative cases from the LANDMARK RCT, insights from quantitative aortography and echocardiography...
